Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Mouth Neoplasms 1Lung Neoplasms 1Kidney Neoplasms 1Esophageal Neoplasms 1

Interventions

pembrolizumab 3Nivolumab 3Taxes 2Polymerase Chain Reaction 2Gene Expression Profiling 2Counseling 2Bupropion 2trastuzumab deruxtecan 1temsirolimus 1motexafin gadolinium 1mogamulizumab 1brodalumab 1belinostat 1Zinc Oxide 1Varenicline 1Valproic Acid 1Tobacco Use Cessation Devices 1Specimen Handling 1Sirolimus 1Sentinel Lymph Node Biopsy 1Ritonavir 1Radiotherapy 1Psychology, Positive 1Psychiatric Rehabilitation 1Pemetrexed 1Paclitaxel 1Nicotine Replacement Therapy 1Nicotine 1Methods 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mouth Neoplasms × mogamulizumab × Genitourinary × Clear all
NCT02946671 2020-03-06

Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients

Osaka University

Phase 1 Completed
16 enrolled
GastrointestinalGenitourinaryHead & NeckThoracic

Esophageal Neoplasms, Kidney Neoplasms, Lung Neoplasms, Mouth Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡